Phase 1 Acute Lymphoblastic Leukemia, Pediatric Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Phase I Dose Finding Study of MB-CART2219.1
LymphomaCLLAcute Lymphoblastic Leukemia, Pediatric
University Hospital Tuebingen36 enrolled2 locationsNCT07108868
Recruiting
Phase 1
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
Refractory Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, PediatricRelapsed Acute Lymphoblastic Leukemia
Tanja Andrea Gruber22 enrolled1 locationNCT04996160
Recruiting
Phase 1Phase 2
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+3 more
University Hospital Heidelberg68 enrolled2 locationsNCT03676504